🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you to our expert faculty Tom Newsom-Davis DrTanyaAhmad Dr Riyaz Shah Dr Samantha Cox #BTOGASCO2025Webinar #LCSM #LungCancer

Absolutely epic ESTRO Breur Award lecture from Professor Corinne Faivre-Finn at The Christie NHS The University of Manchester last week! Energising, eye-opening & moving simultaneously Manchester Cancer Research Centre RTphysics Manchester CRUK Lung Centre CRUK National Biomarker Centre ESTRO EORTC BTOG National Institute for Health and Care Research

Abstracts are invited for the UKLCC Conference 2025! 📣 Held on the 4th November this meeting will gather leading advocates and clinicians to share learning and look to the future. Submit your scientific and service development abstracts by the 5th Sept ow.ly/6YxL50VsVAH

Important awareness piece by BBC News (UK) reminding us that lung cancer is on the rise in people who have never smoked. These are different types of lung cancer and we’re still learning why they occur: radon, pollution, unknown. All of us are at risk. bbc.com/future/article…

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non–Small Cell Lung Cancer. Read full article. brnw.ch/21wTwRe

We are happy to announce that the ETOP Slide deck of the 2025 ASCO Annual Meeting is now available online: etop.ibcsg.org/research-and-n…

📣Updated ESMO #ClinicalPracticeGuideline recommendations in oncogene-addicted metastatic #NSCLC: more #TargetedTherapy agents now available in 1L or at resistance. #LungCancer #mNSCLC #ESMOGuidelines 🔗 ow.ly/v7nE50Wbqsf

Thank you to all our Faculty for this excellent workshop!

This is huge - significant PFS benefit from adjuvant chemotherapy in patients with high risk stage 1A-IIA non-squamous NSCLC #lungcancer - practice changing! BTOG Greater Manchester Cancer Alliance MFT NHS British Thoracic Society (BTS) @iaslc

Podcast Alert: BTOG does ... Locally Advanced Lung Cancer. Tom Newsom-Davis and Emma O'Dowd talk to helen liddicoat, Respiratory Physician, Bronchoscopy Lead and member of the National Faculty for Advanced Bronchoscopy and Endobronchial Ultrasound at NHS Education Scotland.

Previous and current BTOG Chairs celebrating RoyCastleLungCancer 35th birthday behind the famous door Lung cancer screening saves lives, and 🇬🇧leads the world, but we must secure its immediate and long-term future Thank you UK Prime Minister for hosting Sanjay Popat

What an incredible impact Roy Castle Lung Cancer Foundation have had over 35 years on improving outcomes for people diagnosed with lung cancer. An honour to celebrate with friends at Downing Street & also discuss the rapid and comprehensive implementation of #lungcancer screening

Experts like these are the driving force of the NHS, UK research and a lifeline for patients. With the strength of Roy Castle Lung Cancer Foundation behind it, we keep moving forward—bringing hope, care, and change #LCSM #35AnniversaryRCLF Sanjay Popat LungSpecialist Tom Newsom-Davis BTOG

Aman Coonar, SCTS President, with Tom Newsom-Davis, BTOG President, joined forces with patients, clinical leaders, commissioners and politicians to celebrate 35 years of the Roy Castle Lung Cancer Foundation.

Correlation between treatments&outcomes of pts with EGFR-mutated NSCLC that transitioned into SCLC: an international retrospective study in ESMO Open. Poor outcomes despite treatment, primary EGFR mutation maintained upon transformation. esmoopen.com/article/S2059-…

ADOPT-lung TiP paper out in Lung Cancer Journal doi.org/10.1016/j.lung… Neo-adjuvant nivolumab has shown sig. OS benefit in CheckMate-816. The need for 1 additional year of adjuvant immunotherapy is being debated. This trial aims to investigate the added value of adjuvant durvalumab

We need a piggy back Project Orbis approval this side. We have no reimbursed ex20ins EGFR reimbursed options after the mobo fail in the public health system. BTOG

REMINDER: Apply now for our 14th ETOP Residential Workshop. Deadline is 31st July.

In Aug ’21, I was unwell, had 2 biopsies & waited weeks for answers. A liquid biopsy trial gave me an ALK+ #lungcancer diagnosis in 10 days. Now NHS England is rolling this out! 🎙️ Alastair Greystoke & I spoke w Roy Castle Lung Cancer Foundation on this & more: 👉 roycastle.org/our-support/po… #LCSM